Xiaohong Han

15PUBLICATIONS
32CO-AUTHORS
Molecular targetsInnate immunityNanomedicineCancer therapy (excl. chemotherapy and radiation therapy)Medical biochemistry - proteins and peptides (incl. medical proteomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Aug 25, 2025
Multiomics and Single-Cell Insights Reveal a Lysophosphatidic Acid-Mediated Resistant Mechanism to Third-generation EGFR-TKI in Non-Small Cell Lung Cancer.

Ruyun Gao, Ning Lou, Sheng Yang

|Apr 08, 2025
JAK3 A573V and JAK3 M511I mutations in peripheral T-cell lymphoma mediating resistance to anti-PD-1 therapy through the STAT3/PD-L1 pathway.

Ning Lou, Mengwei Yang, Zucheng Xie

|Dec 11, 2024
A Novel IgG-IgM Autoantibody Panel Enhances Detection of Early-stage Lung Adenocarcinoma from Benign Nodules.

Rongrong Luo, Xiying Li, Ruyun Gao

|Oct 26, 2024
Methodological Validation and Inter-Laboratory Comparison of Microneutralization Assay for Detecting Anti-AAV9 Neutralizing Antibody in Human.

Shuangqing Yu, Qian Zhao, Cengceng Zhang

|Jun 05, 2024
Immune responses and reinfection of SARS-CoV-2 Omicron variant in patients with lung cancer.

Chen Chen, Xiaoyun Zhou, Xiaoxing Gao

|Feb 13, 2024
Longitudinal plasma proteomic analysis identifies biomarkers and combinational targets for anti-PD1-resistant cancer patients.

Qiaoyun Tan, Ruyun Gao, Xiaomei Zhang

Pageof 3

Frequent Collaborators

6 joint publications

Yuankai Shi

4 joint publications

Ning Lou

4 joint publications

Le Tang

3 joint publications

Jiarui Yao